Three biotechs start the year with job cuts; Re­gen­eron ex­pands deal with blue­bird spin­out 

El­e­va­tion On­col­o­gy’s CEO and founder is step­ping down im­me­di­ate­ly as the com­pa­ny aban­dons its for­mer lead can­di­date and chops 30% of its work­force.

The com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER